Advanced search
Publication Cover
British Journal of Biomedical Science Volume 67, 2010 - Issue 3
Journal homepage
26
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Potential biomarkers for differentiation of benign prostatic hyperplasia and prostate cancer

N. T. El MelegyDepartments of Biochemistry, Faculty of Medicine, Assiut University, Assiut, EgyptCorrespondence[email protected]
,
H. A. AboulellaDepartments of Urology, Faculty of Medicine, Assiut University, Assiut, Egypt
,
A. M. Abul-FadlDepartments of Biochemistry, Faculty of Medicine, Assiut University, Assiut, Egypt
&
N. A. MohamedDepartments of Biochemistry, Faculty of Medicine, Assiut University, Assiut, Egypt
Pages 109-112 | Accepted 05 Mar 2010, Published online: 23 May 2016

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Christopher J McNally, Mark W Ruddock, Tara Moore & Declan J McKenna. (2020) Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review. Cancer Management and Research 12, pages 5225-5241.
Read now

Articles from other publishers (13)

Serfa Faja & Amir Shoshi. (2022) The Prostate Gland and PSA (Prostate Specific Antigen). European Journal of Natural Sciences and Medicine 5:2, pages 35-43.
Crossref
Ru Wen, Hongjuan Zhao, Dalin Zhang, Chun-Lung Chiu & James D. Brooks. (2022) Sialylated glycoproteins as biomarkers and drivers of progression in prostate cancer. Carbohydrate Research 519, pages 108598.
Crossref
Annalisa Macagno, Alcibiade Athanasiou, Anja Wittig, Ramy Huber, Stephan Weber, Thomas Keller, Martin Rhiel, Bruno Golding & Ralph Schiess. (2020) Analytical performance of thrombospondin-1 and cathepsin D immunoassays part of a novel CE-IVD marked test as an aid in the diagnosis of prostate cancer. PLOS ONE 15:5, pages e0233442.
Crossref
Emma Scott & Jennifer Munkley. (2019) Glycans as Biomarkers in Prostate Cancer. International Journal of Molecular Sciences 20:6, pages 1389.
Crossref
Kathrin Endt, Jens Goepfert, Aurelius Omlin, Alcibiade Athanasiou, Pierre Tennstedt, Anna Guenther, Maurizio Rainisio, Daniel S. Engeler, Thomas Steuber, Silke Gillessen, Thomas Joos & Ralph Schiess. (2017) Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer. PLOS ONE 12:8, pages e0181557.
Crossref
Braira WahidHamid BashirMuhammad BilalKhansa WahidAleena Sumrin. (2017) Developing a deeper insight into reproductive biomarkers. Clinical and Experimental Reproductive Medicine 44:4, pages 159.
Crossref
Fengli Qu, Lian Xia, Chuanxiang Wu, Lijie Liu, Guoliang Li & Jinmao You. (2016) Sensitive and accurate determination of sialic acids in serum with the aid of dispersive solid-phase extraction using the zirconium-based MOF of UiO-66-NH 2 as sorbent . RSC Advances 6:69, pages 64895-64901.
Crossref
Brian T. Helfand & William J. Catalona. (2014) The Epidemiology and Clinical Implications of Genetic Variation in Prostate Cancer. Urologic Clinics of North America 41:2, pages 277-297.
Crossref
Tristan M. Nicholson, Priyanka D. Sehgal, Sally A. Drew, Wei Huang & William A. Ricke. (2013) Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment. Differentiation 85:4-5, pages 140-149.
Crossref
Konstantinos Michalakis, Ioannis Ilias, Aggeliki Triantafyllou, Antonis Polymeris, Ioannis Kastriotis, Aikaterini-Dimitra Chairakaki & Christos Savopoulos. (2012) Detection of prostate cancer by sialic acid level in patients with non-diagnostic levels of prostate-specific antigen. Maturitas 73:4, pages 325-330.
Crossref
E. Killick, E. Bancroft, Z. Kote-Jarai & R. Eeles. (2012) Beyond Prostate-specific Antigen — Future Biomarkers for the Early Detection and Management of Prostate Cancer. Clinical Oncology 24:8, pages 545-555.
Crossref
T.M. Tilli, L.C. Thuler, A.R. Matos, C.M. Coutinho-Camillo, F.A. Soares, E.A. da Silva, A.F. Neves, L.R. Goulart & E.R. Gimba. (2012) Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia. Experimental and Molecular Pathology 92:1, pages 13-19.
Crossref
. (2012) Current World Literature. Current Opinion in Urology 22:1, pages 78-82.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.